A 113

structure given in first source

Also Known As:

2,3-(3-tetradecanoyloxytetradecanoyl)galactosamine-4-phosphate; 2,3-(C14-O-C14)galactosamine-4-phosphate; A-113; D-Galactose, 2-deoxy-2-((1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-, 4-(dihydrogen phosphate) 3-(3-((1-oxotetradecyl)oxy)tetradecanoate), (2(R),3(R))-

Networked: 16 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Barnum, Michael: 1 article (02/2022)
2.	McGee, Shayan A: 1 article (02/2022)
3.	Nesbit, Robert D: 1 article (02/2022)
4.	Ahrens, Katherine A: 1 article (01/2022)
5.	Branum, Amy M: 1 article (01/2022)
6.	Rossen, Lauren M: 1 article (01/2022)
7.	Uddin, Sayeedha F G: 1 article (01/2022)
8.	Womack, Lindsay S: 1 article (01/2022)
9.	Balkau, Beverley: 1 article (11/2021)
10.	Bastard, Jean-Philippe: 1 article (11/2021)

Related Diseases

1.	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/07/2016 - "We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. "
2.	Adenocarcinoma 01/07/2016 - "We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. "
3.	Infections 02/01/2020 - "A total of 527 patients with infection or suspected infection were enrolled in the study, including 324 patients in group A, 113 patients in group B, 22 patients in group C, 68 patients in group D, and 28-day mortality were 38.9%, 17.7%, 31.8%, and 11.8%, respectively, and there was statistically significant difference among four groups (P < 0.05). " 08/01/2003 - "aureus ATCC35556 (S.a.113) and its isogenic mutant expressing unalanylated teichoic acids (dlt(-)) were compared in a tissue cage infection model that used C57BL/6 wt and TLR2-deficient mice. " 01/01/2021 - "During the binding and infection of monocytes, HCMV binds to at least two major cell surface receptors/receptor families: the epidermal growth factor receptor (EGFR) to initiate downstream signaling through the EGFR-PI3K pathway, and to β1- and β3-integrins to initiate downstream signaling through the integrin-c-Src pathway (Nogalski et al. PLoS Pathog 9:e1003463, 2013; Chan et al. Proc Natl Acad Sci U S A 106:22369-22374, 2009; Kim et al. Proc Natl Acad Sci U S A 113:8819-8824, 2016; Wang et al. Nature 424:456-461, 2003; Wang et al. Nat Med 11:515-521, 2005; Yurochko et al. Proc Natl Acad Sci U S A 89:9034-9038, 1992). "
4.	Necrotizing Fasciitis 05/01/2023 - "Compared with an average per year of 8 cases over the previous 4 years, this represents a 113% percent increase in cases of necrotizing fasciitis during the study period (P = .071861). "
5.	Maternal Death 01/01/2022 - "Implementation of the checkbox resulted in an average estimated increase of 7.5 maternal deaths per 100,000 live births (95% confidence interval (CI): 6.3, 8.8) in large urban areas (a 76% increase), 11.6 (95% CI: 9.6, 13.6) in medium/small urban areas (a 113% increase), and 16.6 (95% CI: 12.9, 20.3) in rural areas (a 107% increase), compared with MMRs prior to the checkbox. "

Related Drugs and Biologics

1.	ErbB Receptors (EGF Receptor)
2.	Non-Receptor Type 1 Protein Tyrosine Phosphatase
3.	Adiponectin
4.	Leptin
5.	Integrins
6.	Teichoic Acids
7.	Cell Surface Receptors
8.	Insulin (Novolin)
9.	DNA (Deoxyribonucleic Acid)
10.	N-acetyltalosaminuronic acid (NAT)

Related Therapies and Procedures

1.	Culture Diffusion Chambers